Amin, Alpesh
Keshishian, Allison
Dina, Oluwaseyi
Dhamane, Amol
Nadkarni, Anagha
Carda, Eric
Russ, Cristina
Rosenblatt, Lisa
Mardekian, Jack
Yuce, Huseyin
Baker, Christine L.
Funding for this research was provided by:
Pfizer
Bristol-Myers Squibb
Article History
First Online: 28 March 2019
Change Date: 20 June 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11239-020-02161-0
Compliance with ethical standards
:
: Amin is an employee of the University of California, Irvine and was a paid consultant to Bristol-Myers Squibb in connection with this study and the development of this manuscript. Keshishian is an employee of STATinMED Research, a paid consultant to Pfizer and Bristol-Myers Squibb in connection with this study and the development of this manuscript. Dina, Carda, Russ, Mardekian, and Baker are employees of Pfizer Inc., with ownership of stocks in Pfizer Inc. Dhamane, Nadkarni, and Rosenblatt are employees of Bristol-Myers Squibb Company, with ownership of stocks in Bristol-Myers Squibb Company. Yuce has no conflicts of interest.